source
- BioNTech appoints Guido Oelkers as new CEO, succeeding cofounder Ugur SahinBioNTech announced that Guido Oelkers will become its chief executive officer, taking over from cofounder Ugur Sahin. Oelkers comes from Swedish biopharma Sobi, where he led the company, and bring…
- BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challengerBlossomHill Therapeutics plans to raise $111.7 million to fund the clinical journey of its potential challenger to Tagrisso.Fierce Biotech · 5h ago↗ source
- After 6-month wait, BioNTech announces Sobi CEO will take on top job at mRNA company